Replication of Linkage of Familial Combined Hyperlipidemia to Chromosome 1q With Additional Heterogeneous Effect of Apolipoprotein A-I/C-III/A-IV Locus: The NHLBI Family Heart Study

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.20.10.2275PMID 11031215
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans

  1999cited by this paper
• The human apM-1, an adipocyte-specific gene linked to the family of TNF's and to genes expressed in activated T cells, is mapped to chromosome 1q21.3-q23, a susceptibility locus identified for familial combined hyperlipidaemia (FCH).

  1999cited by this paper
• Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.

  1998cited by this paper
• Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex.

  1998cited by this paper
• Linkage of familial combined hyperlipidaemia to chromosome 1q21–q23

  1998cited by this paper
• Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype.

  1998cited by this paper
• Mapping a gene for combined hyperlipidaemia in a mutant mouse strain

  1998cited by this paper
• Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.

  1998cited by this paper
• No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.

  1997cited by this paper
• Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

  1997cited by this paper
• Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22.

  1996cited by this paper
• NHLBI Family Heart Study: objectives and design.

  1996cited by this paper
• Parametric and nonparametric linkage analysis: a unified multipoint approach.

  1996cited by this paper
• Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.

  1996cited by this paper
• Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia.

  1996cited by this paper
• A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia.

  1995cited by this paper
• Complete multipoint sib-pair analysis of qualitative and quantitative traits.

  1995cited by this paper
• Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results

  1995cited by this paper
• Association between genetic variation at the APO AI‐CIII‐AIV gene cluster and familial combined hyperlipidaemia

  1994cited by this paper
• Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia.

  1994cited by this paper
• Faster sequential genetic linkage computations.

  1993cited by this paper
• A method for accurate amplification of polymorphic CA-repeat sequences.

  1993cited by this paper
• Familial Lipoprotein Disorders in Patients With Premature Coronary Artery Disease

  1992cited by this paper
• Familial combined hyperlipidemia and abnormal lipoprotein lipase.

  1992cited by this paper
• Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24

  1991cited by this paper
• Computer-simulation methods in human linkage analysis.

  1989cited by this paper
• Familial combined hyperlipidemia workshop

  1989cited by this paper
• Strategies for multilocus linkage analysis in humans.

  1984cited by this paper
• Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

  1982cited by this paper
• Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

  1973cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• The investigation of linkage between a quantitative trait and a marker locus

  1972cited by this paper

• A novel mutation in USF1 gene is associated with familial combined hyperlipidemia

  2019cites this paper
• The rs2516839 Polymorphism of the USF1 Gene May Modulate Serum Triglyceride Levels in Response to Cigarette Smoking

  2015cites this paper
• Identification of the differentially expressed genes associated with familial combined hyperlipidemia using bioinformatics analysis

  2015cites this paper
• Before Moving Forward? Complex Trait Locus Linkage Mapping in Atherosclerosis : Time to Take a Step Back

  2013cites this paper
• Genome-Wide Linkage Scan of a Pedigree with Familial Hypercholesterolemia Suggests Susceptibility Loci on Chromosomes 3q25-26 and 21q22

  2011cites this paper
• Regulació de l’expressió gènica en monòcits/macròfags per factors pro-aterogènics. Modulació farmacològica

  2011cites this paper
• Genetic determinants of plasma triglycerides

  2011cites this paper
• Chapter 23 – Lipoprotein Disorders

  2010cites this paper
• Genome-wide and interaction linkage scan for nonsyndromic cleft lip with or without cleft palate in two multiplex families in Shenyang, China.

  2010cites this paper
• Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus

  2010cites this paper
• A Systems Genetics Approach Implicates USF1, FADS3, and Other Causal Candidate Genes for Familial Combined Hyperlipidemia

  2009cites this paper
• CHAPTER 55 – Lipoprotein Disorders

  2009cites this paper
• Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: association study in 2000 Dutch Caucasians.

  2008cites this paper
• Frequent detection of familial hypercholesterolemia mutations in familial combined hyperlipidemia.

  2008cites this paper
• Aspectos genéticos de la hiperlipidemia familiar combinada

  2008cites this paper
• Familial combined hyperlipidaemia: under - defined and under - diagnosed?

  2008cites this paper
• Genetic variants in the Upstream Stimulatory Factor 1 (USF1) gene are associated with LDL cholesterol levels and incident T2DM in women: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

  2008cites this paper
• Molecular Background of Common Dyslipidemias

  2008cites this paper
• Hepatic steatosis in familial combined hyperlipidemia

  2008cites this paper
• Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

  2008cites this paper
• Artículo de revisión Aspectos genéticos de la hiperlipidemia familiar combinada

  2008cites this paper
• Genetic Epidemiology and Lipids: A Pattern So Grand and Complex

  2007influential citation
• Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.

  2007cites this paper
• CHAPTER 8 – Molecular Basis of Lipoprotein Disorders, Atherogenesis, and Thrombosis

  2007cites this paper
• A genome scan for loci influencing levels and trends of lipoprotein lipid-related traits since childhood: The Bogalusa Heart Study.

  2007cites this paper
• High Frequency of a Retinoid X Receptor &ggr; Gene Variant in Familial Combined Hyperlipidemia That Associates With Atherogenic Dyslipidemia

  2007cites this paper
• The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemias⃞ Published, JLR Papers in Press, October 25, 2006.

  2007cites this paper
• Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date

  2007cites this paper
• Unraveling the complex genetics of familial combined hyperlipidemia

  2006cites this paper
• Resting metabolic rate and respiratory quotient : results from a genome-wide scan in the Quebec Family Study 1 – 3

  2006cites this paper
• The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemias⃞

  2006cites this paper
• Can we exclude the TXNIP gene as a candidate gene for familial combined hyperlipidemia?

  2006cites this paper
• Resting metabolic rate and respiratory quotient: results from a genome-wide scan in the Quebec Family Study.

  2006cites this paper
• Association of coronary artery calcified plaque with clinical coronary heart disease in the National Heart, Lung, and Blood Institute's Family Heart Study.

  2006cites this paper
• The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia

  2006cites this paper
• Genetics of familial combined hyperlipidemia

  2006cites this paper
• Manejo de las dislipemias en poblaciones especiales: formas primarias, infancia y adolescencia

  2005cites this paper
• Back Before Moving Forward ? Complex Trait Locus Linkage Mapping in Atherosclerosis : Time to Take a Step

  2005cites this paper
• Complex Trait Locus Linkage Mapping in Atherosclerosis: Time to Take a Step Back Before Moving Forward?

  2005cites this paper
• Hiperlipemia familiar combinada. Criterios diagnósticos y terapéuticos

  2005cites this paper
• The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population

  2005cites this paper
• Visión actualizada de la hiperlipidemia familiar combinada aplicada a la mejora de su diagnóstico

  2005cites this paper
• Linkage of the cholesterol 7alpha-hydroxylase gene and low-density lipoprotein cholesterol conditional on apolipoprotein E association: the National Heart, Lung, and Blood Institute Family Heart Study.

  2005cites this paper
• [Hyperlipidemia: complex pathophysiology caused by multiple genetic and environmental factors--in considering the approaches to preventive medicine].

  2005cites this paper
• Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides

  2005cites this paper
• Familial Combined Hyperlipidemia in Mexicans: Association With Upstream Transcription Factor 1 and Linkage on Chromosome 16q24.1

  2005cites this paper
• Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians.

  2004cites this paper
• CHOLESTEROL AND PREMATURE CORONARY HEART DISEASE

  2004cites this paper
• USF1 on trial

  2004cites this paper
• Diagnostic Criteria in Relation to the Pathogenesis of Familial Combined Hyperlipidemia

  2004cites this paper
• Genome-wide linkage scan reveals multiple susceptibility loci influencing lipid and lipoprotein levels in the Québec Family Study

  2004cites this paper
• Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)

  2004cites this paper
• Identification of novel molecular candidates for fatty liver in the hyperlipidemic mouse model, HcB19 Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.M400062-JLR200

  2004cites this paper
• Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia

  2004cites this paper
• TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study.

  2004cites this paper
• A genome-wide scan of serum lipid levels in the Old Order Amish.

  2004influential citation
• Searching for genes predisposing to common dyslipidemias

  2004influential citation
• Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.

  2004cites this paper
• Genome-wide Scan for Metabolic Syndrome and Related Quantitative Traits in Hong Kong Chinese and Confirmation of a Susceptibility Locus on Chromosome 1 q 21-q 25

  2004cites this paper
• Genetics of familial combined hyperlipidemia and risk of coronary heart disease.

  2004cites this paper
• Diagnóstico y tratamiento de las hiperlipemias familiares

  2004cites this paper
• GENETIC SUSCEPTIBILITY TO THE METABOLIC SYNDROME

  2004cites this paper
• Linkage and association mapping of a chromosome 1q21-q24 type 2 diabetes susceptibility locus in northern European Caucasians.

  2004cites this paper
• Familial Combined Hyperlipidemia: Controversial Aspects of its Diagnosis and Pathogenesis

  2004cites this paper
• Towards mapping QTLs : influencing parameters of lipid metabolism in human twins

  2004cites this paper
• Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility

  2004cites this paper
• [Diagnosis and treatment of familial hyperlipaemia episodes].

  2004cites this paper
• Rat model of familial combined hyperlipidemia as a result of comparative mapping.

  2004cites this paper
• Genome-wide linkage scan reveals multiple susceptibility loci influencing lipid and lipoprotein levels in the Québec Family Studys⃞s⃞ The online version of this article (available at http://www.jlr.org) contains one additional table. Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jl

  2004cites this paper
• Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25.

  2004cites this paper
• Contribution of Chromosome 1q21‐q23 to Familial Combined Hyperlipidemia in Mexican Families

  2004influential citation
• Metabolic and genetic determinants of HDL in families with low HDL cholesterol and premature coronary heart disease

  2004cites this paper
• METABOLIC AND GENETIC DETERMINANTS OF HDL IN FAMILIES WITH LOW HDL CHOLESTEROL AND PREMATURE CORONARY HEART DISEASE

  2004cites this paper
• Genetic disorders of lipoprotein transport in children

  2003cites this paper
• Coronary Artery Disease Risk in Familial Combined Hyperlipidemia and Familial Hypertriglyceridemia: A Case-Control Comparison From the National Heart, Lung, and Blood Institute Family Heart Study

  2003cites this paper
• Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300201-JLR200

  2003cites this paper
• Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment

  2003cites this paper
• Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q.

  2003cites this paper
• Genetics of hypertension

  2003cites this paper
• Coronary Artery Disease Risk in Familial Combined Hyperlipidemia and Familial Hypertriglyceridemia A Case-Control Comparison From the National Heart, Lung, and Blood Institute Family Heart Study Clinical Investigation and Reports

  2003cites this paper
• Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.

  2002cites this paper
• Lack of agreement between the plasma lipid-based criteria and apoprotein B for the diagnosis of familial combined hyperlipidemia in members of familial combined hyperlipidemia kindreds.

  2002cites this paper
• Locus for Elevated Apolipoprotein B Levels on Chromosome 1p31 in Families With Familial Combined Hyperlipidemia

  2002cites this paper
• Small LDL particles, associations with hypertriglyceridemia, lipoprotein modifying enzymes and atherosclerosis

  2002cites this paper
• Positional cloning of the combined hyperlipidemia gene Hyplip1

  2002cites this paper
• Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: evidence for linkage of triglyceride levels to chromosome 19q.

  2002cites this paper
• A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster.

  2002cites this paper
• Family Studies: Their Role in the Evaluation of Genetic Cardiovascular Risk Factors

  2002cites this paper
• LDL oxidation and LDL particle size in the development of atherosclerosis

  2002cites this paper
• Delayed and Exaggerated Postprandial Complement Component 3 Response in Familial Combined Hyperlipidemia

  2002cites this paper
• Mutation screening and association of human retinoid X receptor gamma variation with lipid levels in familial type 2 diabetes.

  2002cites this paper
• Genome Scans for Blood Pressure and Hypertension: The National Heart, Lung, and Blood Institute Family Heart Study*

  2002cites this paper
• Evaluation of apolipoprotein A-II as a positional candidate gene for familial Type II diabetes, altered lipid concentrations, and insulin resistance

  2002cites this paper
• LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.

  2002cites this paper
• Pathophysiology of adipose tissue metabolism and atherosclerosis in familial combined hyperlipidemia

  2001cites this paper
• Genome-Wide Linkage Analysis of Lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study

  2001cites this paper
• Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

  2001influential citation
• Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL

  2001cites this paper
• Genetic dissection of familial combined hyperlipidemia.

  2001cites this paper
• Genetics of type 2 diabetes and the metabolic syndrome

  2001cites this paper